{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T07:29:44Z","timestamp":1750231784943},"reference-count":19,"publisher":"Societas Neurologica Japonica","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rinsho Shinkeigaku"],"published-print":{"date-parts":[[2014]]},"DOI":"10.5692\/clinicalneurol.54.561","type":"journal-article","created":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T23:50:14Z","timestamp":1406937014000},"page":"561-564","source":"Crossref","is-referenced-by-count":7,"title":["Beneficial effects of 3,4-diaminopyridine in a 26-year-old woman with DOK7 congenital myasthenic syndrome who was originally diagnosed with facioscapulohumeral dystrophy"],"prefix":"10.5692","volume":"54","author":[{"given":"Atsuko","family":"Nishikawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madoka","family":"Mori-Yoshimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Oya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiko","family":"Nakata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kinji","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miho","family":"Murata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3663","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Engel AG. The therapy of congenital myasthenic syndromes. Neurotherapeutics 2007;4:252-257.","DOI":"10.1016\/j.nurt.2007.01.001"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Kinali M, Beeson D, Pitt MC, et al. Congenital myasthenic syndromes in childhood: diagnostic and management challenges. J Neuroimmunol 2008;201-202:6-12.","DOI":"10.1016\/j.jneuroim.2008.06.026"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Okada K, Inoue A, Okada M, et al. The muscle protein DOK-7 is essential for neuromuscular synaptogenesis. Science 2006;312:1802-1805.","DOI":"10.1126\/science.1127142"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Inoue A, Setoguchi K, Matsubara Y, et al. Dok-7 activates the muscle receptor kinase MuSK and shapes synapse formation. Sci Signal 2009;2:ra7.","DOI":"10.1126\/scisignal.2000113"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Beeson D, Higuchi O, Palace J, et al. Dok-7 mutations underlie a neuromuscular junction synaptopathy. Science 2006;313:1975-1978.","DOI":"10.1126\/science.1130837"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Cossins J, Liw WW, Belaya K, et al. The spectrum of mutations that underlie the neuromuscular junction synaptopathy in DOK7 congenital myasthenic syndrome. Hum Mol Genet 2012;21:3765-3775.","DOI":"10.1093\/hmg\/dds198"},{"key":"7"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Hamuro J, Higuchi O, Okada K, et al. Mutations causing DOK7 congenital myasthenia ablate functional motifs in Dok-7. J Biol Chem 2008;283:5518-5524.","DOI":"10.1074\/jbc.M708607200"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Servais L, Baudoin H, Zehrouni K, et al. Pregnany in congenital myasthenic syndrome. J Neurol 2013;260:815-819","DOI":"10.1007\/s00415-012-6709-x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Engel AG. Current status of the congenital myasthenic syndromes. Neuromuscul Disord 2012;22:99-111","DOI":"10.1016\/j.nmd.2011.10.009"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Ben Ammar A, Petit F, Alexandri N, et al. Phenotype genotype analysis in 15 patients presenting a congenital myasthenic syndrome due to mutations in DOK7. J Neurol 2010;257:754-766.","DOI":"10.1007\/s00415-009-5405-y"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Felice KJ, Jones JM, Conway SR. Facioscapulohumeral dystrophy presenting as infantile facial diplegia and lateonset limb-girdle myopathy in members of the same family. Muscle Nerve 2005;32:368-372.","DOI":"10.1002\/mus.20344"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Padberg GW, Lunt PW, Koch M, et al. Diagnostic criteria for facioscapulohumeral muscular dystrophy. Neuromuscul Disord 1991;1:231-234.","DOI":"10.1016\/0960-8966(91)90094-9"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Dorobek M, Kabzi\u0144ska D. A severe case of facioscapulohumeral muscular dystrophy (FSHD) with some uncommon clinical features and a short 4q35 fragment. Eur J Paediatr Neurol 2004;8;313-316.","DOI":"10.1016\/j.ejpn.2004.08.004"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Sansone V, Saperstein DS, Barohn RJ, et al. Concurrence of facioscapulohumeral muscular dystrophy and myasthenia gravis. Muscle Nerve 2004;30:679-680.","DOI":"10.1002\/mus.20118"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Lorenzoni PJ, Scola RH, Kay CS, et al. Congenital myasthenic syndrome and minicore-like myopathy with DOK7 mutation. Muscle Nerve 2012;48:151-152.","DOI":"10.1002\/mus.23724"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Lashley D, Palace J, Jayawant S, et al. Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7. Neurology 2010;74:1517-1523.","DOI":"10.1212\/WNL.0b013e3181dd43bf"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Burke G, Hiscock A, Klein A, et al. Salbutamol benefits children with congenital myasthenic syndrome due to DOK7 mutations. Neuromuscul Disord 2013;23;170-175.","DOI":"10.1016\/j.nmd.2012.11.004"},{"key":"19","unstructured":"19) Yamanashi Y, Higuchi O, Beeson D. Dok7\/MuSK signaling and a congenital myasthenic syndrome. Acta Myol 2008;27:25-29."}],"container-title":["Rinsho Shinkeigaku"],"original-title":["\u9854\u9762\u80a9\u7532\u4e0a\u8155\u578b\u7b4b\u30b8\u30b9\u30c8\u30ed\u30d5\u30a3\u30fc\u3068\u8a3a\u65ad\u3055\u308c\u3066\u3044\u305f&lt;i&gt;DOK7&lt;\/i&gt;\u578b\u7b4b\u7121\u529b\u75c7\u306e1\u4f8b"],"language":"en","deposited":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T13:39:41Z","timestamp":1565703581000},"score":1,"resource":{"primary":{"URL":"http:\/\/jlc.jst.go.jp\/DN\/JST.JSTAGE\/clinicalneurol\/54.561?lang=en&from=CrossRef&type=abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.5692\/clinicalneurol.54.561","relation":{},"ISSN":["0009-918X","1882-0654"],"issn-type":[{"value":"0009-918X","type":"print"},{"value":"1882-0654","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}